OTC - ACTIVE INGREDIENT SECTION
Active Ingredient: Salicylic Acid (2.0%)
OTC - PURPOSE SECTION
Purpose:
Acne Treatment
Active Ingredient: Salicylic Acid (2.0%)
Purpose:
Acne Treatment
Uses:
Warnings: For external use only
_____________________________
Using other topical acne drugs at the same time or immediately following the use of this product may increase skin dryness/ irritation. If this occurs, use only one acne drug unless directed by a physician.
_______________________________
Do not use in or near the eyes
Directions:
Inactive Ingredients:
Water/Aqua/Eau, SD Alcohol 40-B, Ethoxydiglycol, Azelaic Acid, Pentylene Glycol, Glycerin, Hydroxyethylcellulose, Butylene Glycol, Potassium Hydroxide, Glycyrrhiza Glabra (Licorice) root extract, Poterium Officinale (Green Burnet) Root, Cinnamomum Cassia Bark, Zingiber Officinale (Ginger) Root.
A gentle and effective 2% salicylic acid acne spot treatment that clears existing acne blemishes while reducing oil production and the occurence of future breakouts
Un traitement doux et effectif a base de 2 % d'acide salicylique pour les boutons d'acne, reduit la production de sebum et la fromation de futures lesions.
pcaskin.com please recycle
2008 Physicians Care Alliance, LLC
Scottsdale, AZ 85253 Made in U.S.A
#21175
Keep out of reach of children.
If swallowed, get medical help or contact a Poison Control Center immediately.
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| SALICYLIC ACID | ACTIVE INGREDIENT | O414PZ4LPZ | 12 | |
| SALICYLIC ACID | ACTIVE MOIETY | O414PZ4LPZ | 12 | |
| 1,3-BUTYLENE GLYCOL | INACTIVE INGREDIENT | 3XUS85K0RA | 12 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | 12 | |
| AZELAIC ACID | INACTIVE INGREDIENT | F2VW3D43YT | 12 | |
| CHINESE CINNAMON | INACTIVE INGREDIENT | WS4CQ062KM | 12 | |
| DIETHYLENE GLYCOL MONOETHYL ETHER | INACTIVE INGREDIENT | A1A1I8X02B | 12 | |
| GINGER | INACTIVE INGREDIENT | C5529G5JPQ | 12 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 12 | |
| LICORICE | INACTIVE INGREDIENT | 61ZBX54883 | 12 | |
| PENTYLENE GLYCOL | INACTIVE INGREDIENT | 50C1307PZG | 12 | |
| POTASSIUM HYDROXIDE | INACTIVE INGREDIENT | WZH3C48M4T | 12 | |
| SANGUISORBA OFFICINALIS ROOT | INACTIVE INGREDIENT | 4NYV2HT01X | 12 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 12 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 68726-068 | 68726-068-02, 68726-068-01, 68726-068-03 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| WATER | 059QF0KO0R | IACT |
| ALCOHOL | 3K9958V90M | IACT |
| AZELAIC ACID | F2VW3D43YT | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| BUTYLENE GLYCOL | 3XUS85K0RA | IACT |
| GINGER | C5529G5JPQ | IACT |
| LICORICE | 61ZBX54883 | IACT |
| POTASSIUM HYDROXIDE | WZH3C48M4T | IACT |
| SANGUISORBA OFFICINALIS ROOT | 4NYV2HT01X | IACT |
| DIETHYLENE GLYCOL MONOETHYL ETHER | A1A1I8X02B | IACT |
| PENTYLENE GLYCOL | 50C1307PZG | IACT |
| CHINESE CINNAMON | WS4CQ062KM | IACT |
| SALICYLIC ACID | O414PZ4LPZ | ACTIB |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| DIETHYLENE GLYCOL MONOETHYL ETHER | DIETHYLENE GLYCOL MONOETHYL ETHER | A1A1I8X02B | GEL / TOPICAL | 2500 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LIQUID / ORAL | 2400 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / TOPICAL | 2445 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / OPHTHALMIC | 0.5 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / RESPIRATORY (INHALATION) | 5 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL, METERED / TRANSDERMAL | 3675 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / DENTAL | 12.8 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / RESPIRATORY (INHALATION) | 0.08 %w/v | ||
| GINGER | GINGER | C5529G5JPQ | SYRUP / ORAL | 0.05 ml/5ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM / VAGINAL | 60 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAMUSCULAR | 450 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | TABLET, DELAYED RELEASE / ORAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, EXTENDED RELEASE / ORAL | 7 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYSTEM / IONTOPHORESIS | 168.1 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CLOTH / TOPICAL | 0.05 mg/mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / TOPICAL | 9971 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / DENTAL | 15 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / TRANSDERMAL | 306.2 mg | ||
| POTASSIUM HYDROXIDE | POTASSIUM HYDROXIDE | WZH3C48M4T | CAPSULE, DELAYED RELEASE / ORAL | 5 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SHAMPOO / TOPICAL | 5 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, METERED / NASAL | 70 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / TOPICAL | 500 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | AEROSOL, FOAM / TOPICAL | 21 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / NASAL | 10 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / TRANSDERMAL | 7360 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DROPS / ORAL | 300 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / SUBCUTANEOUS | 6.1 %v/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / TRANSDERMAL | 500 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LIQUID / TOPICAL | 2.5 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LOTION / TOPICAL | 3990 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / NASAL | 20 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GUM, CHEWING / BUCCAL | 230 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / ORAL | 681 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAMUSCULAR | 1491 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | EMULSION / INTRAVENOUS | 2.2 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | JELLY / VAGINAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, EXTENDED RELEASE / ORAL | 265 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, FILM COATED / ORAL | 1.55 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / INTRAMUSCULAR | 400 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / OPHTHALMIC | 58 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, FOAM / TOPICAL | 4504 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / OPHTHALMIC | 12 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / RECTAL | 0.35 %v/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET / PERIODONTAL | 0.53 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPRAY / NASAL | 22.3 mg/1ml | ||
| POTASSIUM HYDROXIDE | POTASSIUM HYDROXIDE | WZH3C48M4T | CREAM / VAGINAL | 3 mg | ||
| DIETHYLENE GLYCOL MONOETHYL ETHER | DIETHYLENE GLYCOL MONOETHYL ETHER | A1A1I8X02B | GEL / TRANSDERMAL | 87 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL / TOPICAL | 561 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / OPHTHALMIC | 2.5 %w/v | ||
| GINGER | GINGER | C5529G5JPQ | ELIXIR / ORAL | 10 mg/5ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / TOPICAL | 3633 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / ORAL | 3563 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CONCENTRATE / BUCCAL | 679 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / DENTAL | 1.8 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / TOPICAL | 1971 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAVENOUS | 15 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPONGE / TOPICAL | 2 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVESICAL | 7892 mg | ||
| POTASSIUM HYDROXIDE | POTASSIUM HYDROXIDE | WZH3C48M4T | INJECTION / INTRAVENOUS | ADJ PH | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / OPHTHALMIC | 6 %w/v |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ec945104-25c4-3e1f-e053-2a95a90ac559 | 62901840-4d72-4324-b89f-335022d2e5c0 | 2022-11-03 | Warnings | ec945104-25c4-3e1f-e053-2a95a90ac559 62901840-4d72-4324-b89f-335022d2e5c0 |
Adverse event summaries are temporarily unavailable. Other product information remains available.